EE03925B1 - Farmakoloogiliselt aktiivse aine valmistamise meetod - Google Patents

Farmakoloogiliselt aktiivse aine valmistamise meetod

Info

Publication number
EE03925B1
EE03925B1 EEP199900488A EEP9900488A EE03925B1 EE 03925 B1 EE03925 B1 EE 03925B1 EE P199900488 A EEP199900488 A EE P199900488A EE P9900488 A EEP9900488 A EE P9900488A EE 03925 B1 EE03925 B1 EE 03925B1
Authority
EE
Estonia
Prior art keywords
preparation
active substance
pharmacologically active
pharmacologically
substance
Prior art date
Application number
EEP199900488A
Other languages
English (en)
Inventor
Bakonyi M�ria
Csat�rin� Nagy Marianna
Moln�r Levent�n�
Gaj�ry Antal
Alatty�ni Edit
Original Assignee
Sanofi-Synthlabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthlabo filed Critical Sanofi-Synthlabo
Publication of EE9900488A publication Critical patent/EE9900488A/et
Publication of EE03925B1 publication Critical patent/EE03925B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
EEP199900488A 1997-05-13 1998-05-11 Farmakoloogiliselt aktiivse aine valmistamise meetod EE03925B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700885A HU222283B1 (hu) 1997-05-13 1997-05-13 Eljárás tieno[3,2-c]piridin-származékok előállítására
PCT/HU1998/000048 WO1998051689A1 (en) 1997-05-13 1998-05-11 A new process for the preparation of a pharmacologically active substance

Publications (2)

Publication Number Publication Date
EE9900488A EE9900488A (et) 2000-06-15
EE03925B1 true EE03925B1 (et) 2002-12-16

Family

ID=90014236

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900488A EE03925B1 (et) 1997-05-13 1998-05-11 Farmakoloogiliselt aktiivse aine valmistamise meetod

Country Status (38)

Country Link
US (1) US6180793B1 (et)
EP (1) EP0981529B1 (et)
KR (1) KR100428238B1 (et)
CN (1) CN1109036C (et)
AR (1) AR014349A1 (et)
AT (1) ATE212025T1 (et)
AU (1) AU735702B2 (et)
BR (1) BR9809112B1 (et)
CA (1) CA2289623C (et)
CO (1) CO4950564A1 (et)
CZ (1) CZ292820B6 (et)
DE (1) DE69803176T2 (et)
DK (1) DK0981529T3 (et)
DZ (1) DZ2487A1 (et)
EE (1) EE03925B1 (et)
EG (1) EG21973A (et)
ES (1) ES2172141T3 (et)
HK (1) HK1027350A1 (et)
HR (1) HRP980240B1 (et)
HU (1) HU222283B1 (et)
ID (1) ID23018A (et)
IL (1) IL132774A0 (et)
IS (1) IS1883B (et)
ME (1) ME01636B (et)
MY (1) MY121299A (et)
NO (1) NO325419B1 (et)
NZ (1) NZ501577A (et)
PL (1) PL194859B1 (et)
PT (1) PT981529E (et)
RS (1) RS49626B (et)
RU (1) RU2172315C1 (et)
SA (1) SA98190583B1 (et)
SK (1) SK283700B6 (et)
TR (1) TR199902783T2 (et)
TW (1) TW552263B (et)
UA (1) UA66359C2 (et)
WO (1) WO1998051689A1 (et)
ZA (1) ZA983921B (et)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2769313B1 (fr) * 1997-10-06 2000-04-21 Sanofi Sa Derives d'esters hydroxyacetiques, leur procede de preparation et leur utilisation comme intermediaires de synthese
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
IN191030B (et) * 2001-01-24 2003-09-13 Cadila Healthcare Ltd
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
ITMI20020933A1 (it) * 2002-05-03 2003-11-03 Danimite Dipharma S P A Procedimento per la sintesi di clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
US6812363B2 (en) * 2002-10-15 2004-11-02 Usv Limited Racemization of optically active 2-substituted phenyl glycine esters
US20060100231A1 (en) * 2003-03-10 2006-05-11 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (en) 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
KR100553398B1 (ko) * 2004-03-12 2006-02-16 한미약품 주식회사 티에노[3,2-ｃ]피리딘 유도체의 제조 방법 및 이에사용되는 중간체
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
TW200640932A (en) * 2005-02-24 2006-12-01 Teva Pharma Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
KR100681512B1 (ko) 2005-03-08 2007-02-09 주식회사 한서켐 클로피도그렐의 신규한 제조 중간체 및 이를 이용한 클로피도그렐의 제조방법
KR101235117B1 (ko) 2005-12-26 2013-02-20 에스케이케미칼주식회사 광학분리에 의한 (ｓ)-(＋)-클로피도그렐의 제조방법
KR20090013794A (ko) * 2006-04-27 2009-02-05 인드-스위프트 래버러토리즈 리미티드 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
DK2064217T3 (da) 2006-09-04 2011-05-09 Ranbaxy Lab Ltd Forbedret fremgangsmåde til fremstilling af clopidogrel og dets farmaceutisk acceptable salte
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
KR100990949B1 (ko) 2008-06-09 2010-10-29 엔자이텍 주식회사 클로피도그렐 및 그의 유도체의 제조방법
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel
US8563690B2 (en) * 2008-11-03 2013-10-22 The Board Of Trustees Of The University Of Illinois Modulation of platelet aggregation
CN101544655B (zh) * 2009-05-05 2012-07-04 上海医药集团股份有限公司 噻吩并[3，2-c]吡啶衍生物的制备方法
CN101863899B (zh) * 2010-06-21 2013-03-20 常州制药厂有限公司 一种提高氯吡格雷樟脑磺酸盐拆分收率的方法
KR20170004282A (ko) 2015-07-02 2017-01-11 류종렬 수도 지지부가 구비된 쉐이크 핸드형 탁구 라켓
KR20170004283A (ko) 2015-07-02 2017-01-11 류종렬 그립부가 개선된 쉐이크 핸드형 탁구 라켓

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2530247B1 (fr) * 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.

Also Published As

Publication number Publication date
PT981529E (pt) 2002-06-28
DK0981529T3 (da) 2002-04-22
AR014349A1 (es) 2001-02-28
CZ292820B6 (cs) 2003-12-17
HUP9700885A2 (hu) 1999-09-28
HUP9700885A3 (en) 2000-06-28
UA66359C2 (uk) 2004-05-17
MY121299A (en) 2006-01-28
ME01636B (me) 2007-08-03
YU58799A (sh) 2002-06-19
HUP9700885D0 (en) 1997-07-28
WO1998051689A1 (en) 1998-11-19
NO325419B1 (no) 2008-04-21
CN1255924A (zh) 2000-06-07
EE9900488A (et) 2000-06-15
AU735702B2 (en) 2001-07-12
ES2172141T3 (es) 2002-09-16
PL194859B1 (pl) 2007-07-31
ID23018A (id) 1999-12-30
HU222283B1 (hu) 2003-05-28
HK1027350A1 (en) 2001-01-12
KR100428238B1 (ko) 2004-04-30
TW552263B (en) 2003-09-11
HRP980240A2 (en) 1999-02-28
SK151699A3 (en) 2000-07-11
TR199902783T2 (xx) 2000-04-21
CZ393999A3 (cs) 2000-04-12
CA2289623A1 (en) 1998-11-19
IS1883B (is) 2003-08-15
BR9809112A (pt) 2000-08-01
CN1109036C (zh) 2003-05-21
US6180793B1 (en) 2001-01-30
SK283700B6 (sk) 2003-12-02
DE69803176D1 (de) 2002-02-21
NO995533D0 (no) 1999-11-12
AU7444898A (en) 1998-12-08
DZ2487A1 (fr) 2004-07-30
EP0981529A1 (en) 2000-03-01
JP4256478B2 (ja) 2009-04-22
SA98190583B1 (ar) 2006-08-19
EP0981529B1 (en) 2002-01-16
DE69803176T2 (de) 2002-08-22
RU2172315C1 (ru) 2001-08-20
RS49626B (sr) 2007-08-03
CO4950564A1 (es) 2000-09-01
CA2289623C (en) 2007-01-30
EG21973A (en) 2002-05-31
KR20010012511A (ko) 2001-02-15
IL132774A0 (en) 2001-03-19
BR9809112B1 (pt) 2010-10-05
ZA983921B (en) 1998-11-09
HRP980240B1 (en) 2003-02-28
PL336693A1 (en) 2000-07-03
IS5244A (is) 1999-11-11
JP2001525819A (ja) 2001-12-11
ATE212025T1 (de) 2002-02-15
NO995533L (no) 1999-12-13
NZ501577A (en) 2001-10-26

Similar Documents

Publication Publication Date Title
EE03925B1 (et) Farmakoloogiliselt aktiivse aine valmistamise meetod
IS4715A (is) Lyfjafræðilega virk kínasólín efnasambönd
PT1002243E (pt) Metodo para a preparacao de materiais para dispositivos oftalmicos hidrofilicos dobraveis
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
PT1105382E (pt) Metodo para a preparacao de citalopran
ID24654A (id) Formulasi farmasi omeprazola
MA26473A1 (fr) Composes pharmacologiquement actifs.
NO20005218L (no) Farmasöytisk aerosolpreparat
NO973612D0 (no) Nytt farmasöytisk preparat
NO980546D0 (no) Farmasöytiske midler
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
FI970530A0 (fi) Koostumus aktiivisen aineen selektiiviseksi vapauttamiseksi
AP9600857A0 (en) Pharmacologically active compound
ID24677A (id) Kombinasi senyawa aktif fungisidal
DE69528843T2 (de) Pharmakologisch aktive 2-mercaptobenzimidazolderivate
ID23928A (id) Formulasi mengandung insektisida
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO973611D0 (no) Nytt farmasöytisk preparat
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
NO20000811D0 (no) Fremgangsmåte for valg av medicament
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
SE9700660D0 (sv) Pharmaceutically active compounds
SE9704874D0 (sv) New pharmaceutically active compounds
ITMI981215A1 (it) Procedimento migliorato per la preparazione di un derivato pirazolopirimidinonico terapeuticamente attivo

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231